BeyondSpring Announces Planned Start of Phase I Investigator-Initiated Trial of Plinabulin Plus Nivolumab, Enters Immuno-Oncology Space
September 15, 2015 10:17 ET
|
BeyondSpring Pharmaceuticals
NEW YORK, Sept. 15, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...
Data Supporting BeyondSpring's Lead Asset, Plinabulin, to be Presented at WCLC 2015
September 01, 2015 09:16 ET
|
BeyondSpring Pharmaceuticals
NEW YORK, Sept. 1, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...
BeyondSpring to Present Two Posters Supporting Plinabulin at WCLC 2015
August 31, 2015 09:31 ET
|
BeyondSpring Pharmaceuticals
NEW YORK, Aug. 31, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...
BeyondSpring Extends Plinabulin IP Portfolio With Two New Method of Treatment Patent Applications
March 23, 2015 08:30 ET
|
BeyondSpring Pharmaceuticals
NEW YORK, March 23, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...
BeyondSpring Files Composition of Matter Patent Application for Plinabulin Combination Therapy in Immuno-Oncology
February 24, 2015 08:30 ET
|
BeyondSpring Pharmaceuticals
NEW YORK, Feb. 24, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...
BeyondSpring Pharmaceuticals Names Dr. Yan Sun as Principal Investigator for Global Phase 3 Lung Cancer Clinical Trial of Plinabulin
December 09, 2014 08:30 ET
|
BeyondSpring Pharmaceuticals
NEW YORK, Dec. 9, 2014 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, announced that...
BeyondSpring Pharmaceuticals to Conduct Phase 3 Trial of Lead Candidate Plinabulin in NSCLC
December 03, 2014 08:30 ET
|
BeyondSpring Pharmaceuticals
NEW YORK, Dec. 3, 2014 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...